Lobby organisation
Alexion Pharmaceuticals
Business / industry · Health & pharma · HQ: United States · Transparency Register entry
As of 9 September 2026, Alexion Pharmaceuticals appears in 8 declared MEP meetings (7 different MEPs), most often with European People's Party.
In their own words
“Alexion Pharmaceuticals, Inc. now part of Astra Zeneca, is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening diseases that are also ultra-rare. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 8 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (4 in 2024).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 8 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 5 May 2026 | Tomislav Sokol | Health Policy |
| 21 Nov 2024 | Stefan Köhler | Politischer Austausch |
| 20 Nov 2024 | Margarita de la Pisa Carrión | Rare Diseases |
| 4 Nov 2024 | Oliver Schenk | Pharmastandort Deutschland |
| 2 Oct 2024 | Niels Flemming Hansen | Priorities for the mandate |
| 25 Oct 2023 | Tomislav Sokol | Pharmaceutical legislation |
| 7 Sep 2023 | Tiemo Wölken | Revision of the Pharmaceutical Legislation (staff level) |
| 4 Jul 2023 | Andreas Glück | Pharmaceutical legislation |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.